Bjarke Henric Bjorn 4
4 · Inozyme Pharma, Inc. · Filed Mar 17, 2021
Insider Transaction Report
Form 4
Bjarke Henric Bjorn
See Remarks
Transactions
- Award
Stock option (right to buy)
2021-03-04+51,000→ 51,000 totalExercise: $19.78Exp: 2031-03-03→ Common Stock (51,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 4, 2021. The shares underlying the option are scheduled to vest in equal monthly installments from March 4, 2021 through March 4, 2025.